On March 8, 2023 Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, reported that Chief Executive Officer Masoud Toloue will present at Barclays Global Healthcare Conference on Wednesday, March 15, 2023 at 4:35 p.m., EDT (Press release, Quanterix, MAR 8, 2023, View Source [SID1234628364]). In addition, the company will also host in-person one-on-one meetings with institutional investors on March 15.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
For those interested in tuning in to the presentation virtually, please register here: View Source;tp_key=ffe17ea0e1&tp_special=8. Replays of the presentation will be available for a limited period following the conference. The webcast and presentation will also be made available through the Investor Relations section of Quanterix’s website.
To learn more about Quanterix, visit www.quanterix.com/about. To learn more about Quanterix’s Simoa technology, visit: View Source